Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday?

by Vandana Singh, Benzinga Editor

September 9, 2021 8:57 AM | 1 min read | Make a Comment

The stock price of PharmaCyte Biotech Inc PMCB is trading higher during premarket today.
Investors are expecting a major announcement from the company today.
PharmaCyte Biotech will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually today.
"We are extremely honored to present at H.C. Wainwright's 23rd Annual Global Investment Conference. PharmaCyte is forever grateful to H.C. Wainwright for bringing institutional investors to our door so that we could present our story in two separate capital raises that generated about $90 million," said CEO Kenneth L. Waggoner.
Price Action: PMCB stock is up 9.94% at $3.76 during the premarket session on the last check Thursday.

Posted In: Biotech News Penny Stocks Health Care Movers Trading Ideas General Briefs why it's moving

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.